Tempus Labs Raises 80 Million Dollars With Co-Founder Eric Lefkofsky To Find Data For Cancer Treatment

Co-founder Eric Lefkofsky of Tempus Labs has helped to raise 80 million dollars more towards finding cancer molecular data in order to help future cancer patients and cancer patients who are currently battling cancer. Tempus Labs uses Molecular Data along with DNA and RNA from past and current cancer patients along with similarities to create date for how well and how not well treatments work. Without this data cancer treatment probably would not advance much farther but thanks to Tempus Labs located in Chicago, Illinois cancer treatment will now be able to advance much farther so people can get the proper cancer treatments and options that they deserve.

Cancer is an illness that nobody wants to go through let along see a loved one go through it. Eric Lefkofsky is so good at helping Tempus Labs find ways to further advance date and science for cancer because he knows first hand after watching a loved one who was very close to him go through cancer treatment plan just how much needs to be changed with it all. Tempus labs currently work with patients and their doctors to help them find the right treatment options for them based on certain demographics and criteria that they meet and what has worked for patients that have similar demographics and criteria in the past.

Tempus Labs has over 4,000 employees to oversee everything going on in the lab and to help any patients when they might need some guidance or help with finding information or the answer to any question they might have. These employees can also be used to talk to doctors of patients to find a common ground as far as treatment for a patient goes and as to what may or may not work for them. When it comes down to it at the end of the day Tempus Labs is there to provide quality care and services to patients who need peace of mind when it comes to their treatment. Having cancer is stressful enough but it can be even more stressful when you have to deal with the financial aspect of it.

To Learn More Click Here

This entry was posted in Cancer, Research. Bookmark the permalink.